Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
Gurizzan C, Lorini L, Paderno A, Tomasoni M, Zigliani G, Bozzola A, Ardighieri L, Battocchio S, Bignotti E, Ravaggi A, Romani C, De Cecco L, Serafini MS, Miceli R, Bardellini E, Majorana A, Piazza C, Bossi P.
Gurizzan C, et al. Among authors: zigliani g.
BMC Cancer. 2021 May 17;21(1):561. doi: 10.1186/s12885-021-08297-3.
BMC Cancer. 2021.
PMID: 34001010
Free PMC article.